![]() |
市场调查报告书
商品编码
1471083
胚胎培养基市场:按配方、成分和最终用户划分 - 2024-2030 年全球预测Embryo Culture Media Market by Formulations (Bicarbonate-Based Formulations, HEPES-Based Media Formulations), Component (Amino Acids, Antibiotic, Buffer), End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年胚胎培养基市场规模为2.7728亿美元,预计2024年将达3.0525亿美元,2030年将达5.5589亿美元,复合年增长率为10.44%。
胚胎培养基是指用于在体外环境中支持胚胎生长和发育的专门配方,通常用于体外受精 (IVF) 等程序。这些配方旨在模拟输卵管和子宫液,为胚胎从受精卵到胚囊的存活、生长和发育提供重要的必需营养素,确保维持适当的生理环境。全球不孕症的增加增加了对 ART 治疗的需求,从而增强了胚胎培养基市场。此外,生殖技术的创新、体外受精成功率的提高以及体外受精治疗意识的提高也推动了市场的成长。然而,体外受精程序和相关培养基的高成本可能是一个限制因素,特别是在成本敏感地区。也就是说,投资客製化和增强培养基的研发以改善胚胎发育和妊娠结局可能会为市场创造机会主义景观。此外,开发更接近自然子宫环境的培养基以提高胚胎植入和生长速度可能会推动市场成长。
主要市场统计 | |
---|---|
基准年[2023] | 27728万美元 |
预测年份 [2024] | 30525万美元 |
预测年份 [2030] | 55589万美元 |
复合年增长率(%) | 10.44% |
配方:基于 HEPES 的培养基配方的采用正在迅速增加,因为它们能够在周围大气条件下保持稳定的 pH 值。
基于碳酸氢盐的配方通常在胚胎培养基中用作缓衝系统,以维持胚胎髮育的最佳 pH 值。培养箱中的二氧化碳 (CO2) 与培养基中的碳酸氢盐相互作用,产生稳定 pH 值的缓衝液。这些配方需要具有精确 CO2 水平的受控气氛,以将 pH 值保持在适合胚胎培养的狭窄范围内。以碳酸氢盐为基础的培养基主要用于体外环境,在体外环境中可以密切监测和调节条件,并提供接近女性生殖道内自然条件的环境。以 HEPES 为基础的培养基配方使用缓衝剂 HEPES(4-(2-羟乙基)-1-哌嗪乙磺酸)来维持胚胎培养基的 pH 稳定性。 HEPES不需要CO2调节,可以在大气条件下维持稳定的pH值。这使得基于 HEPES 的培养基特别适用于在培养箱受控环境之外对胚胎进行短期处理和操作,例如在卵母细胞取出、受精和胚胎移植期间。
胚胎培养基中抗生素的研究进展
胺基酸是胚胎培养基的重要组成部分,并充当发育中胚胎中蛋白质合成的基础材料。胺基酸促进各种代谢过程并有助于调节渗透压和 pH 值。必需胺基酸不能在体内合成,必须透过培养基提供。这些对于胚胎生长和发育、影响细胞分裂、形态发生和代谢调节至关重要。非必需胺基酸可以由细胞合成,因此不需要外源性供应,通常包含在培养基中以支持胚胎的最大生长和发育,从而增加胚胎细胞的活力和功能。有时会在胚胎培养基中添加抗生素,以防止细菌污染,从而损害胚胎的活力和发育。缓衝液有助于保持培养基的 pH 值稳定,这对于胚胎的正常生长和代谢至关重要。常见的缓衝剂包括碳酸氢盐和HEPES。将螯合剂添加到培养基中以螯合二价阳离子,例如钙和镁。葡萄糖、丙酮酸和乳酸等能量基材提供细胞分裂和增殖所需的能量。 pH 指标对于即时监测培养基的 pH 值非常重要。 pH值的变化对胚胎有害,因此可以立即进行调整以维持最佳环境。盐构成渗透平衡的基础,并为细胞过程提供必需的离子。胚胎培养基中常见的盐类包括氯化钠、氯化钾、氯化钙和硫酸镁。
最终用户:在生育诊所中越来越多地使用胚胎培养基
学术和研究机构对于生殖技术和胚胎学研究的进步极为重要。他们广泛使用胚胎培养基来进行胚胎发育、遗传学和辅助生殖技术(ART)的研究。这些机构可能从事了解胚胎生长的基础研究或具有直接临床意义的应用研究,从而改善培养基配方和胚胎存活率。由于直接参与体外受精 (IVF) 等 ART 程序,生育诊所是胚胎培养基的主要最终用户。这些诊所使用高品质的培养基来优化胚胎生长条件,这对于提高植入和怀孕成功率非常重要。生育诊所也努力透过客製化培养基来满足患者生殖细胞的独特需求,为寻求不孕症治疗的患者提供最佳结果。设有生殖医学科的医院也使用胚胎培养基,特别是提供体外受精(IVF)和其他ART服务时。医院胚胎学家在将胚胎植入患者子宫之前使用培养液来维持和生长胚胎。医院的高标准护理通常需要使用顶级胚胎培养基,以最大限度地提高妊娠成功的机会,特别是对于面临复杂生殖挑战的患者。
区域洞察
由于美国和加拿大等主要经济体的不孕症盛行率较高、有利的报销政策以及支持辅助生殖技术(ART)的医疗保健基础设施的建立,新兴经济体的胚胎培养基市场正在不断增长。 。欧洲、中东和非洲地区呈现出成熟市场和新兴市场结合的成长格局。欧盟国家对 ART 及相关产品有严格的规定。有利的法律规范和医疗保健政策正在增加 ART 诊所的数量并提高胚胎培养基的普及。欧盟最近的专利反映出对胚胎培养技术和配方创新的关注,以提高体外受精的成功率。同时,由于生育诊所的不断增加以及人们对 ART 文化态度的改变,中东地区的需求不断增长。由于人口基数高、可支配收入增加以及不孕症治疗意识不断增强,亚太地区正在迅速开拓新兴市场。由于政府的支持措施和 ART 医疗保健支出的增加,日本、印度和中国等经济体的市场正在成长。
FPNV定位矩阵
FPNV定位矩阵对于评估胚胎培养基市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对胚胎文化媒体市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.胚胎培养基市场的市场规模与预测是多少?
2.胚胎文化媒体市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些?
3.胚胎培养基市场的技术趋势和法规结构是什么?
4.胚胎培养基市场主要供应商的市场占有率为何?
5. 进入胚胎培养基市场的合适形式和策略性手段是什么?
下载 PDF 副本
[182 Pages Report] The Embryo Culture Media Market size was estimated at USD 277.28 million in 2023 and expected to reach USD 305.25 million in 2024, at a CAGR 10.44% to reach USD 555.89 million by 2030.
Embryo culture media refers to specialized formulations used to support the growth and development of embryos in an in vitro environment, commonly utilized during procedures such as in vitro fertilization (IVF). These formulations are designed to simulate the oviduct and uterine fluids, providing essential nutrients and maintaining a suitable physiological environment crucial for embryo survival, growth, and development from the zygote to the blastocyst stage. A global increase in infertility issues has led to greater demand for ART treatments, subsequently bolstering the market for embryo culture media. Moreover, innovations in reproductive technologies and improvements in success rates of IVF procedures, creating awareness of IVF treatment, also add to the market growth. However, the high cost of ART procedures and associated culture media can be a limiting factor, particularly in cost-sensitive regions. Nevertheless, investments in research and development for customized and enhanced culture media to improve embryo development and pregnancy outcomes may provide an opportunistic landscape for the market. Moreover, developing culture media that mimics the natural uterine environment more closely to enhance embryo implantation and growth rates may bolster market growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 277.28 million |
Estimated Year [2024] | USD 305.25 million |
Forecast Year [2030] | USD 555.89 million |
CAGR (%) | 10.44% |
Formulations: Burgeoning adoption of HEPES-based media formulations as they can maintain a stable pH under ambient atmospheric conditions
Bicarbonate-based formulations are commonly used as buffering systems in embryo culture media to maintain an optimal pH level for embryo development. Carbon dioxide (CO2) in the incubator interacts with the bicarbonate in the media, creating a buffer that stabilizes the pH. These formulations require a controlled atmosphere with precise CO2 levels to ensure the pH remains within the narrow range suitable for embryo culture. The use of bicarbonate-based media is predominant in an in vitro setting where the conditions can be closely monitored and regulated, providing an environment that closely mimics the natural conditions within the female reproductive tract. HEPES-based media formulations use the buffering agent HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) to maintain pH stability in embryo culture media. HEPES can maintain a stable pH under ambient atmospheric conditions without needing CO2 regulation. This makes HEPES-based media particularly useful for short-term handling and manipulation of embryos outside the controlled environment of an incubator, such as during egg retrieval, fertilization, or embryo transfer.
Component: Advancements of antibiotics in embryo culture media
Amino acids are crucial components of embryo culture media, serving as the building blocks for protein synthesis within the developing embryo. They facilitate various metabolic processes and contribute to regulating osmolality and pH. Essential amino acids cannot be synthesized by the organism and must be provided through the culture media. They are vital for the growth and development of the embryo, influencing cell division, morphogenesis, and metabolic regulation. Non-essential amino acids, while not required to be supplied exogenously as they can be synthesized by cells, are often included in culture media to support maximal growth and development of embryos, potentially enhancing embryonic cell viability and function. Antibiotics may be added to embryo culture media to prevent bacterial contamination that can compromise the viability and development of the embryos. Buffers help maintain a stable pH in the culture media, which is essential for the normal growth and metabolism of embryos. Common buffering agents include bicarbonate and HEPES. Chelators are added to culture media to sequester divalent cations such as calcium and magnesium, which may be present in toxic concentrations or may interfere with the function of other media components. Energy substrates such as glucose, pyruvate, and lactate provide the necessary energy for cell division and growth. They are critical for sustaining the metabolic activity of developing embryos. pH indicators are important for real-time monitoring of the culture media's pH level. Changes in pH can be detrimental to the embryo, and thus, immediate adjustments can be made to maintain an optimal environment. Salts form the basis of the osmotic balance and provide essential ions for cellular processes. Common salts in embryo culture media include sodium chloride, potassium chloride, calcium chloride, and magnesium sulfate.
End-User: Evolving utilization of embryo culture media by fertility clinics
Academic and research institutes are pivotal in advancing reproductive technologies and studying embryology. They utilize embryo culture media extensively for conducting research in embryonic development, genetics, and assisted reproductive technology (ART) practices. These institutes may be engaged in basic research to understand embryonic growth and applied research with direct clinical implications, potentially leading to enhancements in culture media formulation and resultant embryonic viability. Fertility clinics are a primary end-user of embryo culture media, given their direct involvement in ART procedures such as in vitro fertilization (IVF). These clinics rely on high-quality culture media to optimize embryo growth conditions, critical for improving implantation and pregnancy success rates. Fertility clinics also work towards customizing the culture media to suit the specific needs of the patient's reproductive cells, thereby ensuring the best possible outcomes for patients seeking assistance with fertility. Hospitals with reproductive medicine departments also utilize embryo culture media, particularly in settings where IVF and other ART services are provided. The hospital embryologists use culture media to maintain and nurture embryos before they are transferred to the patient's uterus. High standards of care in hospitals often necessitate the use of top-tier embryo culture media to maximize the potential for successful pregnancies, particularly for patients with complex reproductive challenges.
Regional Insights
The embryo culture media market shows a developed landscape across the Americas region owing to a higher prevalence of infertility issues, favorable reimbursement policies, and established healthcare infrastructure supporting assisted reproductive technologies (ART) in major economies such as the U.S. and Canada. The EMEA region showcases a mixed growth scenario with mature and emerging markets. EU countries have stringent regulations governing ART and related products. Favorable regulatory frameworks and healthcare policies have increased ART clinics and advanced embryo culture media adoption rates. Recent patents within the EU reflect the focus on innovation in embryo culture techniques and formulations to improve IVF success rates. Meanwhile, the Middle East is experiencing growing demand due to the increasing establishment of fertility clinics and a shift in cultural attitudes towards ART. The Asia Pacific region is experiencing a rapidly developing embryo culture media market due to the high population base, increasing disposable incomes, and awareness of infertility treatments. Economies including Japan, India, and China showcase increased market growth with supportive government initiatives and rising healthcare expenditure toward ART.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Embryo Culture Media Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Embryo Culture Media Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Embryo Culture Media Market, highlighting leading vendors and their innovative profiles. These include Ann Arbor-based Incept BioSystems Inc., Becton, Dickinson and Company, City Fertility, Cook Group Incorporated, CooperSurgical, Inc., Cytiva, Inc., Esco Group, ESCO MicroGenea, FertiPro NV, Fertitech Canada Inc., Genea Biomedx, GYNEMED GmbH & Co. KG, Hamilton Thorne Inc., InVitroCare Inc., INVO Bioscience, Irvine Scientific by FUJIFILM Corporation, Kitazato Corporation, Labotect Labor-Technik-Gottingen GmbH, Medical Technology Group, Merck KGaA, Nidacon International AB, NMC Healthcare, Thermo Fisher Scientific, Inc., and Vitrolife Sweden AB.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Embryo Culture Media Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Embryo Culture Media Market?
3. What are the technology trends and regulatory frameworks in the Embryo Culture Media Market?
4. What is the market share of the leading vendors in the Embryo Culture Media Market?
5. Which modes and strategic moves are suitable for entering the Embryo Culture Media Market?
Download PDF Copy